Publication | Closed Access

Health-Related Quality-of-Life in a Randomized Phase III First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients from Asia with Advanced NSCLC (IPASS)

Advanced NsclcOncologyCancer ManagementClinical TrialsPharmacotherapyHealth-related Quality-of-lifeCancer TreatmentMedicineGefitinib Versus Carboplatin/paclitaxel